Description
Cabergoline Oral Therapy – Dopamine Agonist for Hormonal Balance & Prolactin Regulation
Cabergoline is a potent dopamine D2 receptor agonist used to manage hyperprolactinemia, a condition characterized by abnormally high prolactin levels. Elevated prolactin can interfere with reproductive hormone function and lead to symptoms such as irregular periods, infertility, decreased libido, erectile dysfunction, and galactorrhea (milk discharge not related to breastfeeding).
By acting on the pituitary gland, Cabergoline reduces prolactin secretion, helping to restore hormonal balance and improve overall endocrine health. It is frequently used as part of hormone replacement therapy (HRT) programs, especially in patients with signs of elevated prolactin that may be suppressing normal testosterone or estrogen production.
Common Uses:
- Treatment of hyperprolactinemia
- Restoration of menstrual regularity and ovulation
- Support for fertility in both men and women
- Addressing low libido or sexual dysfunction
- Adjunct therapy in hormone optimization protocols
Formulation & Administration:
- Form: Oral tablet
- Typical Dosage: 0.25mg to 0.5mg twice weekly (individualized by provider)
- Route: Oral, with or without food
Clinical Considerations:
- Baseline and follow-up prolactin levels are recommended
- May be used short- or long-term based on therapeutic goals
- Should be used under the guidance of a licensed medical provider
Cabergoline is compounded in collaboration with licensed pharmacies to ensure quality and dosing flexibility.
Important Information & Disclaimer
Compounded drug products have not been evaluated by the FDA for safety, efficacy, or quality. This therapy is available by prescription only and should be used under medical supervision. Individual results and side effects may vary.
